The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
in Japan there are many people with a mutation in CTP so they have very low CTP and initially the first report said these people live longer than we do and they are free of coronary disease so then loss of function of CTP became a longevity Gene it is still by many people called a longevity Gene because if you don't have it you live longer you have less Alzheimer you have less diabetes and in general you are just simply more healthy
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.